CITI/CALL/INTUITIVE SURGICAL/280/0.1/19.12.24 | Delayed Deutsche Boerse AG 11:39:15 2024-07-12 am EDT | ||
| 15.77 EUR | -2.29% |
|
| Current month | -1.22% | ||
| 1 month | +16.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
INTUITIVE SURGICAL, INC.
Latest news about INTUITIVE SURGICAL, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 15.77 | -2.29% |
| 24-07-11 | 16.14 | +1.45% |
| 24-07-10 | 15.91 | +0.63% |
| 24-07-09 | 15.81 | -0.82% |
| 24-07-08 | 15.94 | +0.57% |
Delayed Quote Deutsche Boerse AG
Last update July 12, 2024 at 11:39 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | INTUITIVE SURGICAL, INC. |
| Issuer | 
Citi
|
| WKN | KH9CJA |
| ISIN | DE000KH9CJA6 |
| Date issued | 2023-08-23 |
| Strike | 280 $ |
| Maturity | 2024-12-19 (160 Days) |
| Parity | 10 : 1 |
| Emission price | 5.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.52 € |
|---|---|
| Lowest since issue | 3.5 € |
Company Profile
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (60%): primarily wrist cuffs;
- sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.4%).
The United States accounts for 65.8% of net sales.
Sector
-
Consensus: Intuitive Surgical, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
443.5
USD
Average target price
432.3
USD
Spread / Average Target
-2.53%
- Stock Market
- Warrants
- Warrant
